Zoetis Shares Plummets 0.38% as Trading Volume Dives to $430M Ranking 266th in U.S. Market

Zoetis (ZTS) closed on Sept. 25 with a 0.38% decline, marking its lowest performance in recent sessions. The stock's trading volume dropped to $430 million, a 28.56% decrease from the previous day, ranking it 266th among active U.S. equities. Market participants noted reduced liquidity as a key factor in the muted price action.

Analysts observed that the biopharmaceutical company's shares have been consolidating amid mixed industry sentiment. While veterinary healthcare demand remains stable, investors appear cautious about near-term earnings visibility. The volume contraction suggests limited fresh buying interest, with institutional activity appearing subdued compared to the prior week's trading pattern.

For back-testing purposes, the proposed strategy involves daily re-ranking of NYSE/Nasdaq-listed stocks by dollar volume, purchasing the top 500 names at next-day open prices, and exiting at close. This approach, tested from Jan. 3, 2022, to Sept. 25, 2025, uses equal weighting and assumes zero transaction costs. Confirmation is required for universe parameters, pricing assumptions, and rebalancing frequency before execution.